Inventor · disambiguated record
Richard R. Lesniewski
Also filed as: LESNIEWSKI RICHARD · LESNIEWSKI RICHARD R
8 granted patents·6 pending applications·123 citations·filing 1995–2024
86Inventor score
Top patents by PatentIndex Score
14 records- 0179US6596476B1Hepatitis C assayABBOTT LAB·Filed 1997·Granted Jul 22, 2003·64 cites·14 claims
- 0277US2025074987A1Cancer therapyMADISON VACCINES INC·Filed 2024·Application pending·0 cites
- 0376US8748108B2Biomarkers for identifying patient classesMCKEEGAN EVELYN M·Filed 2011·Granted Jun 10, 2014·6 cites·9 claims
- 0474US2024115684A1Cancer therapyMADISON VACCINES INC·Filed 2023·Application pending·0 cites
- 0572US6593083B1Hepatitis C assay utilizing recombinant antigensFiled 2000·Granted Jul 15, 2003·4 cites·26 claims
- 0672US6172189B1Hepatitis C assay utilizing recombinant antigensABBOTT LAB·Filed 1997·Granted Jan 9, 2001·32 cites·4 claims
- 0765US11806391B2Combinatorial method of treating prostate cancerMADISON VACCINES INC·Filed 2021·Granted Nov 7, 2023·0 cites·5 claims
- 0856US6020122AHepatitis C virus second envelope (HCV-E2) glycoprotein expression systemABBOTT LAB·Filed 1995·Granted Feb 1, 2000·17 cites·4 claims
- 0953US11000578B2Treatment of prostate cancer with pap vaccine and PD-1 inhibitor co-therapyMADISON VACCINES INC·Filed 2017·Granted May 11, 2021·0 cites·16 claims
- 1049US2010184026A1Companion Diagnostic Assays For Endothelin Receptor AntagonistsABBOTT LAB·Filed 2009·Application pending·0 cites
- 1145US2015211075A1Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancersABBVIE INC·Filed 2015·Application pending·0 cites
- 1244US2008102451A1Companion diagnostic assays for endothelin receptor antagonistsABBOTT LAB·Filed 2006·Application pending·0 cites
- 1342US9045800B2Methods and compositions for identifying, classifying and monitoring subject having Bcl-2 family inhibitor-resistant tumors and cancersSEMIZAROV DIMITRI·Filed 2010·Granted Jun 2, 2015·0 cites·22 claims
- 1440US2022133873A1Cancer therapyMADISON VACCINES INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →